• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC-SUNNYVALE/APTUS ENDOSYSTEMS ENDO ANCHOR SYSTEM - HELI-FX TAA; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC-SUNNYVALE/APTUS ENDOSYSTEMS ENDO ANCHOR SYSTEM - HELI-FX TAA; CATHETER, PERCUTANEOUS Back to Search Results
Model Number HA-18-114
Device Problem Device Dislodged or Dislocated (2923)
Patient Problem Injury (2348)
Event Date 10/12/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
The aptus applier was selected for prophylactic treatment.It was reported that during the index procedure, upon deployment of the first aptus endoanchor in the distal arch, the endoanchor came loose.The physician was able to snare the endoanchor and remove it from the patient.The diameter of the proximal landing zone was 40-42mm.No further treatment was performed and the patient did not have any complications.No additional clinical sequelae were reported and the patient is fine.
 
Manufacturer Narrative
Evaluation of the returned device has been completed.The exact cause of the mis-deployed endoanchor cannot be definitely determined although the deformation suggests the endoanchor encountered significant resistance during deployment.Based on historical analysis of similar complaints, there is no evidence of a material defect that would have been contributory to the deformation.Conditions that have historically been identified as causes of deployment resistance include: positioning of the heli-fx applier at an angle relative to the vessel wall during deployment, endograft/cuff material infolding or oversizing, and calcification in the area of deployment as well as not maintaining adequate pressure/apposition during deployment.If the heli-fx applier is not positioned perpendicular to the vessel wall with sufficient forward pressure and proper apposition or in an area of calcium or highly concentrated or loose endograft/cuff material, it increases the likelihood the endoanchor will encounter resistance as it is deployed.The excess torque is transmitted directly to the endoanchor leading to its deformation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDO ANCHOR SYSTEM - HELI-FX TAA
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
MEDTRONIC-SUNNYVALE/APTUS ENDOSYSTEMS
271 gibraltar dr
sunnyvale CA 94089
Manufacturer (Section G)
MEDTRONIC CARDIOVASCULAR
3576 unocal place
santa rosa CA 95403
Manufacturer Contact
eric elliott
3576 unocal place
santa rosa, CA 95403
7075912586
MDR Report Key5206292
MDR Text Key30578034
Report Number2953200-2015-01906
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K140036
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/17/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2017
Device Model NumberHA-18-114
Device Catalogue NumberHA-18-114
Device Lot Number49372012
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/17/2015
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/12/2015
Initial Date FDA Received11/05/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received12/08/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/16/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00075 YR
-
-